These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2084129)

  • 1. Gradient high-performance liquid chromatographic assay for the determination of the novel indoloquinone antitumour agent E09 in biological specimens.
    Binger M; Workman P
    J Chromatogr; 1990 Nov; 532(2):321-36. PubMed ID: 2084129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitive isocratic high-performance liquid chromatographic determination of a novel indoloquinone cytotoxic drug (EO9) in human plasma and urine.
    Schellens JH; Loos W; Beijnen JH; Stoter G; Verweij J
    J Chromatogr; 1993 Jun; 615(2):309-15. PubMed ID: 8335709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I and pharmacologic study of the novel indoloquinone bioreductive alkylating cytotoxic drug E09.
    Schellens JH; Planting AS; van Acker BA; Loos WJ; de Boer-Dennert M; van der Burg ME; Koier I; Krediet RT; Stoter G; Verweij J
    J Natl Cancer Inst; 1994 Jun; 86(12):906-12. PubMed ID: 8196081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical studies with EO9, a new indoloquinone bioreductive alkylating cytotoxic agent. EORTC Early Clinical Trials Group.
    Verweij J; Aamdal S; Schellens J; Koier I; Lund B
    Oncol Res; 1994; 6(10-11):519-23. PubMed ID: 7620220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics, distribution, and metabolism of the novel bioreductive alkylating indoloquinone EO9 in rodents.
    Workman P; Binger M; Kooistra KL
    Int J Radiat Oncol Biol Phys; 1992; 22(4):713-6. PubMed ID: 1544843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of EO9 anti-tumour activity by hydralazine.
    Bibby MC; Sleigh NR; Loadman PM; Double JA
    Eur J Cancer; 1993; 29A(7):1033-5. PubMed ID: 8499134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid chromatographic assay for the simultaneous determination of indole-3-carbinol and its acid condensation products in plasma.
    Anderton MJ; Jukes R; Lamb JH; Manson MM; Gescher A; Steward WP; Williams ML
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Apr; 787(2):281-91. PubMed ID: 12650751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-performance liquid-chromatographic analysis of dopachrome and dihydroxyphenylalanine.
    Kågedal B; Konradsson P; Shibata T; Mishima Y
    Anal Biochem; 1995 Mar; 225(2):264-9. PubMed ID: 7762789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purity profile of the indoloquinone anticancer agent EO-9 and chemical stability of EO-9 freeze dried with 2-hydroxypropyl-beta-cyclodextrin.
    van der Schoot SC; Vainchtein LD; Nuijen B; Gore A; Mirejovsky D; Lenaz L; Beijnen JH
    Pharmazie; 2008 Nov; 63(11):796-805. PubMed ID: 19069239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fully automated high-performance liquid chromatographic method for the determination of carzelesin (U-80,244) and metabolites (U-76,073 and U-76,074) in human plasma.
    van Tellingen O; Pels EM; Henrar RE; Schaaf LJ; Padbury GE; Beijnen JH; Nooijen WJ
    J Chromatogr; 1994 Jan; 652(1):51-8. PubMed ID: 8014227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological properties of a new aziridinylbenzoquinone, RH1 (2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone), in mice.
    Loadman PM; Phillips RM; Lim LE; Bibby MC
    Biochem Pharmacol; 2000 Apr; 59(7):831-7. PubMed ID: 10718341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-performance liquid chromatographic analysis of the new antitumour drug N-benzoylstaurosporine (CGP 41 251) and four potential metabolites in micro-volumes of plasma.
    van Gijn R; Havik E; Boven E; Vermorken JB; ten Bokkel Huinink WW; van Tellingen O; Beijnen JH
    J Pharm Biomed Anal; 1995 Dec; 14(1-2):165-74. PubMed ID: 8833979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological approach towards the development of indolequinone bioreductive drugs based on the clinically inactive agent EO9.
    Loadman PM; Bibby MC; Phillips RM
    Br J Pharmacol; 2002 Nov; 137(5):701-9. PubMed ID: 12381684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purity determinations in the bulk drug of the novel indoloquinone antitumor agent EO9.
    Jonkman-de Vries JD; Kettenes-van den Bosch JJ; Henrar RE; Bult A; Beijnen JH
    Invest New Drugs; 1996; 14(2):181-91. PubMed ID: 8913839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-substituted analogues of 3-hydroxymethyl-5-aziridinyl-1-methyl-2-[1H-indole-4,7-dione]prop-2-en- 1-ol (EO9, NSC 382459) and their regioisomers as hypoxia-selective agents: structure-cytotoxicity in vitro.
    Jaffar M; Naylor MA; Robertson N; Lockyer SD; Phillips RM; Everett SA; Adams GE; Stratford IJ
    Anticancer Drug Des; 1998 Mar; 13(2):105-23. PubMed ID: 9524554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioreductive activation of a series of analogues of 5-aziridinyl-3-hydroxymethyl-1-methyl-2-[1H-indole-4, 7-dione] prop-beta-en-alpha-ol (EO9) by human DT-diaphorase.
    Phillips RM
    Biochem Pharmacol; 1996 Dec; 52(11):1711-8. PubMed ID: 8986133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-performance liquid chromatographic assay for the experimental anticancer agent oxantrazole.
    Frank SK; Mathiesen DA; Whitfield LR; Ames MM
    J Chromatogr; 1987 Aug; 419():225-32. PubMed ID: 3667780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of mitiglinide in rat plasma by high-performance liquid chromatography with UV detection.
    Lushan Y; Su Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Apr; 834(1-2):204-7. PubMed ID: 16520101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-performance liquid chromatographic assay for the determination of the novel etoposide derivative dimethylaminoetoposide (NK611) and its metabolites in urine of cancer patients.
    De Fusco M; D'Incalci M; Gentili D; Reichert S; Zucchetti M
    J Chromatogr B Biomed Appl; 1995 Feb; 664(2):409-14. PubMed ID: 7780594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a novel in vitro assay for assessing drug penetration into avascular regions of tumours.
    Phillips RM; Loadman PM; Cronin BP
    Br J Cancer; 1998 Jun; 77(12):2112-9. PubMed ID: 9649122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.